Beyond CD, the IL‐2 WBA shows promise as a versatile research and clinical tool across autoimmune, allergic, malignant, and infectious diseases where circulating antigen‐specific T cells are often present at low frequencies. This evidence concerns the gene IL2 and infectious disease.